Edward White
Stock Analyst at HC Wainwright & Co.
(1.78)
# 3,156
Out of 4,876 analysts
372
Total ratings
25.29%
Success rate
-8.14%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.76 | +325.26% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $5.80 | +193.10% | 41 | Apr 15, 2025 | |
| INZY Inozyme Pharma | Reiterates: Buy | $16 | $3.99 | +301.00% | 14 | Apr 10, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $7.47 | +100.80% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $1.73 | +246.82% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $2.17 | +637.33% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.62 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $8.68 | +821.66% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $2.30 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $1.47 | +1,260.54% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.61 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.03 | +428.05% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.28 | +298.09% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.81 | +890.34% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.78 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.63 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $36.72 | +49.78% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $9.03 | +465.10% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.33 | +110.21% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $4.33 | +1,193.30% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $9.91 | +212.82% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.02 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.29 | +9,521.99% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $21.37 | +40.38% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.04 | +1,053.85% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.76
Upside: +325.26%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $5.80
Upside: +193.10%
Inozyme Pharma
Apr 10, 2025
Reiterates: Buy
Price Target: $16
Current: $3.99
Upside: +301.00%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $7.47
Upside: +100.80%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $1.73
Upside: +246.82%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $2.17
Upside: +637.33%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.62
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $8.68
Upside: +821.66%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.30
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $1.47
Upside: +1,260.54%
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.61
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.03
Upside: +428.05%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.28
Upside: +298.09%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.81
Upside: +890.34%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.78
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.63
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $36.72
Upside: +49.78%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $9.03
Upside: +465.10%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $3.33
Upside: +110.21%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $4.33
Upside: +1,193.30%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $9.91
Upside: +212.82%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.02
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.29
Upside: +9,521.99%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $21.37
Upside: +40.38%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.04
Upside: +1,053.85%